← Leaderboards
Courtney E Sulentic
Michigan State University
$2,698,980
Attributed
$2,878,060
Total exposure
4
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $449.3K · FY2007–17$500K$375K$250K$125K$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
Funding mix
By agency
NIH$2,878,060 · 4
By mechanism
R01$1,367,455 · 1
R25$1,042,485 · 1
R21$358,160 · 1
F32$109,960 · 1
Top collaborators
- Jeffrey B. Travers2 shared
Most similar at Michigan State University
Same institution · by research overlap
- Rory B Conolly$2,586,612
- Jamie J Bernard$2,792,877
- Norbert E Kaminski$22,158,924
Others in their field
Top investigators on “Programs”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,641,009,751
- Leonard Freedman · Leidos Biomedical Research, Inc.$994,984,644
- Lawrence Corey · Fred Hutchinson Cancer Center$730,186,538
- Sonia M Thomas · Research Triangle Institute$700,865,642
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Larry Arthur$609,313,548
Research focus
ProgramsDioxinsAntigensProteinsMediatingImmunityEnvironmental ChemicalEvaluationGene ExpressionChromatin ImmunoprecipitationElementsEnhancersAryl Hydrocarbon ReceptorAryl Hydrocarbon Receptor LigandChimeric ProteinsElectrophoretic Mobility Shift AssayAhr GeneB Cell DifferentiationB-LymphocytesBinding (Molecular Function)Cell LineBurkitt LymphomaAffectAgonist
Grant awards (19)
Photodynamic Therapy-Induced Immune Modulation: Mechanisms and Influence on Therapeutic Efficacy$162,800
R21 · FY2017 · AR
Photodynamic Therapy-Induced Immune Modulation: Mechanisms and Influence on Therapeutic Efficacy$195,360
R21 · FY2016 · AR
Biomedical Scholars Program$262,922
R25 · FY2015 · GM · contact PI
Biomedical Scholars Program$262,922
R25 · FY2014 · GM · contact PI
Biomedical Scholars Program$253,719
R25 · FY2013 · GM · contact PI
Biomedical Scholars Program$262,922
R25 · FY2012 · GM · contact PI
3'alpha enhancer regulation by AhR and NF-kappaB/Rel proteins$217,085
R01 · FY2011 · ES · contact PI
3'alpha enhancer regulation by AhR and NF-kappaB/Rel proteins$11,378
R01 · FY2011 · ES · contact PI
3'alpha enhancer regulation by AhR and NF-kappaB/Rel proteins$219,278
R01 · FY2010 · ES · contact PI
3'alpha enhancer regulation by AhR and NF-kappaB/Rel proteins$16,820
R01 · FY2010 · ES · contact PI
3'alpha enhancer regulation by AhR and NF-kappaB/Rel proteins$221,492
R01 · FY2009 · ES · contact PI
3'alpha enhancer regulation by AhR and NF-kappaB/Rel proteins$221,238
R01 · FY2009 · ES · contact PI
3'alpha enhancer regulation by AhR and NF-kappaB/Rel proteins$6,532
R01 · FY2009 · ES · contact PI
3'alpha enhancer regulation by AhR and NF-kappaB/Rel proteins$221,492
R01 · FY2008 · ES · contact PI
3'alpha enhancer regulation by AhR and NF-kappaB/Rel proteins$226,013
R01 · FY2007 · ES · contact PI
3'alpha enhancer regulation by AhR and NF-kappaB/Rel proteins$6,127
R01 · FY2007 · ES · contact PI
AHR SIGNALING PATHWAY AND B CELL INHIBITION BY TCDD$44,212
F32 · FY2002 · ES
AHR SIGNALING PATHWAY AND B CELL INHIBITION BY TCDD$34,832
F32 · FY2001 · ES
AHR SIGNALING PATHWAY AND B CELL INHIBITION BY TCDD$30,916
F32 · FY2000 · ES